Fundraising Fox

NextGen Jane

Oakland, US · Founded 2014 · Delaware corporation · 1 known investors

nextgenjane.com

NextGen Jane operates a longitudinal molecular study of women's menstruation, collecting samples through a patented at-home kit to generate genomic insights into reproductive and gynecological health. The company serves women seeking to understand menstrual cycles, fertility, and conditions like endometriosis through advanced diagnostics and personalized health insights.

BiotechDigital HealthFemTechHealthtechin /nextgen-jane-inc.@nextgenjane

Founders & leadership

SG
Stephen GireDirector
RT
Ridhi TariyalExecutive Officer, Director

Investors · 1

Reported raises · per SEC filings

Form D private placements
$7MraisedOct 2023 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen GireExecutive Officer, Director
  • Deborah KilpatrickDirector
  • Ridhi TariyalExecutive Officer, Director
  • Adam SharkawyDirector
Offering amount
$7.8M
Amount sold
$7M
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedJun 2022 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • STEPHEN GIREExecutive Officer, Director
  • RIDHI TARIYALExecutive Officer, Director
  • DEBORAH KILPATRICKDirector
  • ADAM SHARKAWYDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.7MraisedApr 2019 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam SharkawyDirector
  • Stephen GireExecutive Officer, Director
  • Ridhi TariyalExecutive Officer, Director
  • Deborah KilpatrickDirector
Offering amount
$8.7M
Amount sold
$8.7M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.2MraisedMar 2016 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen GireDirector
  • Ridhi TariyalExecutive Officer, Director
Offering amount
$2.4M
Amount sold
$2.2M
First sale
Feb 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.